Use of drosophila melanogaster as a model for screening...

Details Use of drosophila melanogaster as a model for screening... Use of drosophila melanogaster as a model for screening...

2001-02-22

2003-09-09

Guzo, David (Department: 1636)

Multicellular living organisms and unmodified parts thereof and

Method of using a transgenic nonhuman animal in an in vivo...

C800S008000, C800S013000, C800S022000, C424S725000, C424S774000

Reexamination Certificate

active

06617491

ABSTRACT:

FIELD OF THE INVENTION
This invention relates to the identification and use of
Drosophila melanogaster
as a model for screening of plant materials useful as psyhchostimulants.
BACKGROUND OF THE INVENTION
Drugs that stimulate or depress CNS play an important role in human therapeutics. They act as anesthetics, analgesics, sedatives, psychostimulants, analeptics, antidepressants, anticonvulsants etc. and are used in the treatment of conditions such as narcolepsy, depression, hyperactivity disorders, epilepsy and drug addiction in human (Wood-Smith and Stewart, 1964, “Drugs In Anesthetic Practice,” Butterworth; Beckman, 1958, “Drugs, Their Nature, Action and Use,” W.B. Saunder, Green and Levy, 1976, “Drug Misuse, Human Abuse,” Dekker). Undesirable side effects and ineffectiveness of currently available CNS stimulants/depressants in many situations call for development of novel drugs. A variety of CNS active drugs have originated, and many of them are waiting to originate, from plants (Wood-Smith and Stewart, 1964, “Drugs In Anesthetic Practice,” Butterworth; Beckman, 1958, “Drugs, Their Nature, Action and Use,” W.B. Saunder; Green and Levy, 1976, “Drug Misuse, Human Abuse,” Dekker; Plotkin, 2000, “Medicine Quest, In Search of Nature's Healing Secrets,” Viking; Gratzar, 2000, Nature 206:235-236). A reason why neuroactive compounds made by plants work on receptors in human brain is also known in the art (Lam et al, 1998, Nature 396:125-126). Keeping the above in view, the applicants used plant materials for screening neuroactive agents.
The applicants recently developed a
Drosophila melanogaster
model for in vivo whole organism based screening of CNS active agents (Sharma and Kumar, a method for screening of central nervous system active agents, U.S. patent application Ser. No. 09/789,525, filed concurrently herewith, the entire disclosure of which is incorporated herein by reference.In particular, the applicant showed that a change in the extent of time required by Sh
5
eag
1
mutant flies to recover from ether anesthesia could be used as a criterion for rapid screening of CNS stimulant/depressant agents. In the present invention, this fruit fly has been used as a model for screening of plant materials.
The plant material screened and studied by the applicants was an extract obtained from
Acorus calamus. Acorus calamus
Linn. is a plant commonly used in Ayurvedic medicine. Its roots and rhizomes are used in various ailments, including many mental disorders, such as hysteria, insanity, insomnia, melancholia, neurasthenia, epilepsy, diarrhoea and asthma (Nadkarni, 1927, The Indian materia medica, Bombay, 26; Kirtikar and Basu, 1933, Indian medicinal plants, vol. IV, Lalit Mohan Basu, Allahabad, p.2626). The common Indian names of the plant are Ugargandha (Saskrit), ghor bach (Hindi), Bacha (Urdu), Wasa (Telugu) and Sweet flag (English).
Modern studies on the neuropharmacological actions of
Acorus calamus
have demonstrated CNS activity in roots and rhizomes, not leaves, of the plant (Bhakuni et al, 1988, Ind. J. Exp. Biol. 26:883-904; Bhakuni et al, 1969, Ind. J. Exp. Biol., 7:250-262). Mainly, CNS depressant actions of
Acorus calamus
have been reported (Zanoli et al, 1998, Phytother, Res. 12:S114-S116; Panchal et al, 1989, Ind. J. Exp. Biol. 27:561-567; Dandiya and Sharma, 1962, Ind. J. Med. Res. 50:46-60; Chopra et al, 1954, Ind. J. Med. Res. 42:381384; Menon and Dandiya, 1966, J. Pharm, Pharmac. 19:170-175; Dhalla et al, 1961, J. Pharmaceut. Sci. 50:580-582; Dhalla and Bhattacharya, 1968, Arch. Int. Pharmacodyn. 172:356-365; Madan et al, 1960; CXXIV:201-211; Dandiya and Menon, 1965, Life Sci. 4:1635-1641).
The active principles identified are asarone and &bgr;-asarone, obtained from roots and rhizomes after steam distillation of volatile oil. Various workers have mainly characterized as having CNS depressant actions such as sedative, tranquilizing, hypnosis potentiation, anticonvulsant, spontaneous motor activity antagonizing, amphetamine induced hyperactivity, antagonizing and analgesic activities to roots and rhizomes of
Acorus calamus.
A CNS stimulant action of the oil from the plant has been reported by Chopra et al, 1954, md. J. Med. Res., 42:381-384). The authors have however given no proof in support of their statement. It is possible that the generalized convulsions induced by &bgr;-asarone might have made these workers ascibe a stimulant property to
Acorus calamus
(Panchal and Venkatkrishna-Bhatt, 1989, Ind. J. Exp. Biol. 27:561-567; Dandiya and Sharma, 1962, Ind. J. Med. Res., 50:46-60). In addition, based on the studies related to the effect of asarone on the leamed behaviour of the rats it has been suggested that the substance may cause a stimulant action at a higher dose and depression at a lower dosage (Dandiya and Sharma, 1962, Ind .J. Med. Res., 50:46-60).
Thus, in the prior art, only roots and rhizomes, not leaves, of
Acorus calamus
are known to possess drug-like activities. Also, the known neuroactivities, of the plant are limited to actions such as sedation, tranquilizing, hypnosis potentiation and convulsions.
Therefore, the extract obtained from the leaves of this plant was screened for CNS stimulant/depressant activity. The Applicants, to their surprise found that the extract works as an excellent CNS stimulant/depressant.
OBJECTS OF THE INVENTION
The main object of the invention is to provide a method whereby plant materials can be screened to test their efficacy as CNS depressant/stimulants.
Another object of the invention is to provide a method for treatment of poisoning, narcolepsy, depression, hyperactivity disorders, alcohol/drug addiction etc. in humans.
SUMMARY OF THE INVENTION
The invention provides a method for screening of plant materials as CNS stimulant/depressant using
Drosophila melanogaster
as a model.
DETAILED DESCRIPTION OF THE INVENTION
Accordingly, the invention provides a novel method whereby plant materials can be screened for their efficacy as CNS stimulant/depressants. The extract of several plants including
Acorus calamus
was tested for CNS stimulation/depression activity in the mutant fruit fly
Drosophila melanogaster
Sh
5
eag
1
.
The invention provides a method for the detection of the analeptic and psychostimulant properties of extract obtained from
Acorus calamus,
using
Drosophila melanogaster
Sh
5
eag
1
said method comprising the steps of:
(a) preparing acetone and methanol extracts of leaves of the plant
Acorus calamus,
(b) treating Sh
5
eag
1
Drosophila melanogaster
mutant flies in the media selected from normal fly food, normal food mixed with phenobarbital, normal food mixed with ethanol, normal food mixed with the alcoholic sample prepared above, normal food mixed with both the alcoholic sample prepared above and phenobarbital and normal food mixed with both the alcoholic sample of step (a) and ethanol,
(c) subjecting differently treated flies to ether anesthesia and then determining extent of time required by them to recover,
(d) observing spontaneous locomotor activity in the differently treated flies and increase in the spontaneous locomotor activity is indicative of analeptic activity of extract of
Acorus calamus
against ethanol,
(e) Observing the recovery time following ether and chloroform anesthesia in flies not pretreated with phenobarbital wherein quick recovery of the flies is indicative of analeptic activity of the extract against phenobarbital,
(f) Observing the recovery time in flies anesthetized with ether and pretreated with phenobarbital, wherein quick recovery of the flies is indicative of analeptic activity of the extract,
(g) observing the spontaneous locomotor activity of the flies under the influence of ethanol, wherein quick recovery of the flies is indicative of analeptic activity of the extract and
(h) observing the spontaneous locomotor activity of the flies not under the influence of ethanol, wherein quick recovery of the flies is indicative of the psychostimulant activity of the extract.
In an embodiment, the extract of
Acorus calamus
is directly used or used

Affiliated with

Also associated with

Rating

Use of drosophila melanogaster as a model for screening... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of drosophila melanogaster as a model for screening..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of drosophila melanogaster as a model for screening... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3107835